Skip to content

EyePoint, Inc. EYPT Return on assets

Return on assets at other companies

Merck & Co. logo
Merck & Co.MRK
7.3%-8.4pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
11.3%-1.2pp
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-51%+17.1pp
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
-76.4%+67.2pp
HRO
HarrowHROW
-10.5%+5.0pp
Theravance Biopharma logo
Theravance BiopharmaTBPH
28.1%+20.5pp

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+108%
Enterprise value$1.15B+122%
P/S158.5×+148×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Calculated from EyePoint, Inc. ’s reported figures.

Based on trailing twelve months.

The official record: EyePoint, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's return on assets?
EyePoint, Inc. (EYPT) reported return on assets of -83.5% in Q1 2026.
How has EyePoint, Inc. 's return on assets changed year-over-year?
EyePoint, Inc. 's return on assets decreased by 96.7% year-over-year, from -42.4% to -83.5%.
What is the long-term trend for EyePoint, Inc. 's return on assets?
Over 5 years (2020 to 2025), EyePoint, Inc. 's return on assets has grown at a 1.5% compound annual growth rate (CAGR), from -55.1% to -59.3%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.